Below are the most recent publications written about "Actuarial Analysis" by people in Profiles.
-
Linton SJ, Gross D, Schultz IZ, Main C, C?t? P, Pransky G, Johnson W. Prognosis and the identification of workers risking disability: research issues and directions for future research. J Occup Rehabil. 2005 Dec; 15(4):459-74.
-
Monahan J, Steadman HJ, Robbins PC, Appelbaum P, Banks S, Grisso T, Heilbrun K, Mulvey EP, Roth L, Silver E. An actuarial model of violence risk assessment for persons with mental disorders. Psychiatr Serv. 2005 Jul; 56(7):810-5.
-
Stuart B, Briesacher BA, Shea DG, Cooper B, Baysac FS, Limcangco MR. Riding the rollercoaster: the ups and downs in out-of-pocket spending under the standard Medicare drug benefit. Health Aff (Millwood). 2005 Jul-Aug; 24(4):1022-31.
-
Pieters RS, Niemierko A, Fullerton BC, Munzenrider JE. Cauda equina tolerance to high-dose fractionated irradiation. Int J Radiat Oncol Biol Phys. 2006 Jan 01; 64(1):251-7.
-
Polin RS, Marko NF, Ammerman MD, Shaffrey ME, Huang W, Anderson FA, Caputy AJ, Laws ER. Functional outcomes and survival in patients with high-grade gliomas in dominant and nondominant hemispheres. J Neurosurg. 2005 Feb; 102(2):276-83.
-
Zhao Y, Ash AS, Ellis RP, Ayanian JZ, Pope GC, Bowen B, Weyuker L. Predicting pharmacy costs and other medical costs using diagnoses and drug claims. Med Care. 2005 Jan; 43(1):34-43.
-
Varlotto JM, Flickinger JC, Niranjan A, Bhatnagar AK, Kondziolka D, Lunsford LD. Analysis of tumor control and toxicity in patients who have survived at least one year after radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys. 2003 Oct 01; 57(2):452-64.
-
Maron BJ, Casey SA, Hauser RG, Aeppli DM. Clinical course of hypertrophic cardiomyopathy with survival to advanced age. J Am Coll Cardiol. 2003 Sep 03; 42(5):882-8.
-
Stone RM, Berg DT, George SL, Dodge RK, Paciucci PA, Schulman PP, Lee EJ, Moore JO, Powell BL, Baer MR, Bloomfield CD, Schiffer CA. Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine. Blood. 2001 Aug 01; 98(3):548-53.
-
Monahan J, Steadman HJ, Appelbaum PS, Robbins PC, Mulvey EP, Silver E, Roth LH, Grisso T. Developing a clinically useful actuarial tool for assessing violence risk. Br J Psychiatry. 2000 Apr; 176:312-9.